UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 5, 2019 9:00 A.M.
Form:
S-1
CIK:
0001321834
Company Name:
Akers Biosciences, Inc.
File Number:
333-234447